(The Conversation) – A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes. He ...

New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.

Researchers at Washington University School of Medicine in St. Louis have shown in a new study that GLP-1 medications may be effective at treating and preventing substance-use disorders across all ...

A major new study out of the Department of Veterans Affairs’ St. Louis Health Care System found that GLP-1 medications, the class of drugs that includes Ozempic, Wegovy, Mounjaro and Zepbound, are ...

Researchers analyze 2.2 million genomes to show that addiction risk is primarily driven by broad genes affecting brain wiring ...

Weight-loss drugs such as Wegovy and Ozempic may become the new frontline warriors in treating and preventing drug and alcohol addiction, a large new study shows. The research, published Wednesday in ...

Most of the genetic risk for developing a substance use disorder comes from genes that broadly affect how our brains process rewards, regulate impulses and weigh consequences—not from genes that ...

Having kids hear from people with lived experience can help move the needle ...

The roots of addiction risk may lie in how young brains function long before substance use begins, according to a new study from Weill Cornell Medicine. The investigators found that children with a ...